Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- Estrogen Patch Shortages Are Ongoing—Here’s Where to Find Them and What to Ask Your Doctor.
- Toddlers are getting their hands on e-cigarettes and inhaling at an alarming rate, new Rutgers study shows.
- Rutgers deans: We train advanced practice nurses for N.J. Our laws send them elsewhere.
- Push for raw milk intensifies across the US, despite illness outbreaks and scientists’ warnings.
- Princeton undergraduates build real-world skills through community health micro-internships.
Categories
- Community (2,494)
- Covid (1,001)
- CTO Events (6)
- News (3,166)
- Pilots (21)